Scientific Reports, 2025
Proteomic risk scores for predicting common diseases using linear and neural network models in the UK biobank

Smith A., Elliott P., Mayr M. et al.

Nature Communications, 2025
Air pollution-induced proteomic alterations increase the risk of child respiratory infections

Brustad N., Wang T., He S. et al.

Nature Communications, 2025
Shared genetic architecture of posttraumatic stress disorder with cardiovascular imaging, risk, and diagnoses

Shen J., Valentim W., Friligkou E. et al.

International Journal of Molecular Sciences, 2025
Identification of Potential Therapeutic Targets for Coronary Atherosclerosis from an Inflammatory Perspective Through Integrated Proteomics and Single-Cell Omics

Wang H., Xie F., Wang M. et al.

BMC Neurology, 2025
Circulating inflammatory cytokines and the risk of myasthenia gravis: a bidirectional Mendelian randomization study

Su B., He Z., Shi L. et al.

Journal for ImmunoTherapy of Cancer, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Patel S., Fisher J., Chae Y. et al.

The Journal of Clinical Endocrinology & Metabolism, 2025
Multiomics of Human Obesity and Related Multisystem Diseases

Anwar M., Highland H., Sheng Q. et al.

International Journal of Surgery, 2025
Plasma proteomics profiles predict the risk of future aortic aneurysm and aortic dissection

Li M., He X., Gong W. et al.

Gut Microbes, 2025
Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration

Zhang M., Huang X., Zhang Y. et al.

Signal Transduction and Targeted Therapy, 2025
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab

Toulmonde M., Guégan J., Spalato-Ceruso M. et al.

Cancer Cell, 2025
Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma

Huang F., Liu Z., Song Y. et al.

Depression and Anxiety, 2025
Proteomic Biomarkers as Mediators in the Association Between Air Pollution and Incident Depression and Anxiety: Evidence From the UK Biobank

Wang M., Ma Y., Zheng Y. et al.

Neurological Sciences, 2025
Circulating inflammatory proteins as pathogenic mediators and potential therapeutic targets in myasthenia gravis

Chen K., Zeng C., Ren Y. et al.

Kidney International, 2025
Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis

Gupta S., Mistry K., Alikhan F. et al.

JACC: Advances, 2025
Hepatocyte Growth Factor

Holt M., Michelsen A., Flø A. et al.

European Journal of Preventive Cardiology, 2025
Evaluation of Large-Scale Plasma Proteomics for Prediction of Heart Failure in Individuals with A Full Range of Glucose Metabolism Profiles

Zhang Y., Hou R., Sun W. et al.

Science Translational Medicine, 2025
Epigenetic attenuation of interferon signaling is associated with aging-related improvements in systemic lupus erythematosus

Narendra R., Van Phan H., Patterson S. et al.

Cell, 2025
Systematic profiling reveals betaine as an exercise mimetic for geroprotection

Geng L., Ping J., Wu R. et al.

Addiction Biology, 2025
Protein Associations With Alcohol Consumption and Genetic Risk for Alcohol‐Related Sociomedical Conditions

Drouard G., Palviainen T., Kuo C. et al.

Cancer Epidemiology, Biomarkers & Prevention, 2025
The effect of circulating proteins and their role in mediating adiposity’s effect on endometrial cancer risk: Mendelian randomisation and colocalization analyses

Wang S., Tan V., Yarmolinsky J. et al.